SCOPE: Genetic Study Reaches 100-Patient Milestone, October 2020

AG Yost announced a 100-patient enrollment milestone reached in the genetic study of opioid use disorder undertaken by his Scientific Committee on Opioid Prevention and Education (SCOPE).